ASRS
YMAB

Arizona State Retirement System’s Y-mAbs Therapeutics YMAB Stock Holding History

Arizona State Retirement System’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,121
Closed -$203K – 2299
2021
Q3 		$203K Buy
7,121
+56
+0.8% +$1.76K ﹤0.01% 2072
2021
Q2 		$239K Buy
+7,065
New +$227K ﹤0.01% 2014
2021
Q1 		– Sell
-5,802
Closed -$287K – 2139
2020
Q4 		$287K Sell
5,802
-196
-3% -$9.07K ﹤0.01% 1747
2020
Q3 		$230K Buy
+5,998
New +$239K ﹤0.01% 1719

Other funds holding YMAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Arizona State Retirement System's YMAB Position: Q4 2021 in Review

Arizona State Retirement System sold out of Y-mAbs Therapeutics (YMAB) in Q4 2021, closing a stake of 7,121 shares — an estimated $203K sold.

Arizona State Retirement System first reported a position in YMAB in Q3 2020 and held it in 4 quarters. The position peaked at $287K in Q4 2020. 97 funds tracked by Wall St. Rank hold YMAB as of Q4 2021.

  • Arizona State Retirement System reported no remaining Y-mAbs Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Arizona State Retirement System sold 7,121 Y-mAbs Therapeutics shares in Q4 2021, an estimated $203K.
  • Arizona State Retirement System first reported a position in Y-mAbs Therapeutics in Q3 2020 and held it in 4 quarters.
  • Arizona State Retirement System's Y-mAbs Therapeutics position peaked at $287K in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q4 2021.

Based on Arizona State Retirement System's 13F filing for Q4 2021, filed 4 Feb 2022.